Report Detail
Global Anti-inflammatory Therapeutics Market 2024 by Company, Regions, Type and Application, Forecast to 2030
- RnM3369506 |
- 26 September, 2024 |
- Global |
- 104 Pages |
- GIR (Global Info Research) |
- Pharma & Healthcare
Anti-inflammatory therapeutics are treatments for arthritis, respiratory diseases, dermatology, psoriasis, inflammatory bowel disease and other inflammatory diseases. The treatments include anti-inflammatory biologics, NSAIDs, corticosteroids and others.
According to our (Global Info Research) latest study, the global Anti-inflammatory Therapeutics market size was valued at US$ 121270 million in 2023 and is forecast to a readjusted size of USD 181020 million by 2030 with a CAGR of 6.0% during review period.
Top 5 manufacturers make up the major market share in the anti-inflammatory therapeutics market. AbbVie maintained its first place in the ranking in 2019, accounted for 21.59% market share. Other players accounted for 14.20%, 5.43%, 5.32% including Johnson & Johnson, Amgen Inc, AstraZeneca PLC.
This report is a detailed and comprehensive analysis for global Anti-inflammatory Therapeutics market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global Anti-inflammatory Therapeutics market size and forecasts, in consumption value ($ Million), 2019-2030
Global Anti-inflammatory Therapeutics market size and forecasts by region and country, in consumption value ($ Million), 2019-2030
Global Anti-inflammatory Therapeutics market size and forecasts, by Type and by Application, in consumption value ($ Million), 2019-2030
Global Anti-inflammatory Therapeutics market shares of main players, in revenue ($ Million), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Anti-inflammatory Therapeutics
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Anti-inflammatory Therapeutics market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AbbVie, Johnson & Johnson, Amgen Inc, AstraZeneca PLC, Pfizer, Inc, Novartis, Roche, Merck, Sanofi, GlaxoSmithKline, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Anti-inflammatory Therapeutics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segmentation
Anti-inflammatory Therapeutics market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Anti-inflammatory Biologics
Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
Corticosteroids
Others
Market segment by Application
Arthritis
Respiratory Diseases
Dermatology
Gastroenterology
Others
Market segment by players, this report covers
AbbVie
Johnson & Johnson
Amgen Inc
AstraZeneca PLC
Pfizer, Inc
Novartis
Roche
Merck
Sanofi
GlaxoSmithKline
Sun Pharmaceutical Industries Ltd
TEVA
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Anti-inflammatory Therapeutics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Anti-inflammatory Therapeutics, with revenue, gross margin, and global market share of Anti-inflammatory Therapeutics from 2019 to 2024.
Chapter 3, the Anti-inflammatory Therapeutics competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Anti-inflammatory Therapeutics market forecast, by regions, by Type and by Application, with consumption value, from 2024 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Anti-inflammatory Therapeutics.
Chapter 13, to describe Anti-inflammatory Therapeutics research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Classification of Anti-inflammatory Therapeutics by Type
- 1.3.1 Overview: Global Anti-inflammatory Therapeutics Market Size by Type: 2019 Versus 2023 Versus 2030
- 1.3.2 Global Anti-inflammatory Therapeutics Consumption Value Market Share by Type in 2023
- 1.3.3 Anti-inflammatory Biologics
- 1.3.4 Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
- 1.3.5 Corticosteroids
- 1.3.6 Others
- 1.4 Global Anti-inflammatory Therapeutics Market by Application
- 1.4.1 Overview: Global Anti-inflammatory Therapeutics Market Size by Application: 2019 Versus 2023 Versus 2030
- 1.4.2 Arthritis
- 1.4.3 Respiratory Diseases
- 1.4.4 Dermatology
- 1.4.5 Gastroenterology
- 1.4.6 Others
- 1.5 Global Anti-inflammatory Therapeutics Market Size & Forecast
- 1.6 Global Anti-inflammatory Therapeutics Market Size and Forecast by Region
- 1.6.1 Global Anti-inflammatory Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
- 1.6.2 Global Anti-inflammatory Therapeutics Market Size by Region, (2019-2030)
- 1.6.3 North America Anti-inflammatory Therapeutics Market Size and Prospect (2019-2030)
- 1.6.4 Europe Anti-inflammatory Therapeutics Market Size and Prospect (2019-2030)
- 1.6.5 Asia-Pacific Anti-inflammatory Therapeutics Market Size and Prospect (2019-2030)
- 1.6.6 South America Anti-inflammatory Therapeutics Market Size and Prospect (2019-2030)
- 1.6.7 Middle East & Africa Anti-inflammatory Therapeutics Market Size and Prospect (2019-2030)
2 Company Profiles
- 2.1 AbbVie
- 2.1.1 AbbVie Details
- 2.1.2 AbbVie Major Business
- 2.1.3 AbbVie Anti-inflammatory Therapeutics Product and Solutions
- 2.1.4 AbbVie Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
- 2.1.5 AbbVie Recent Developments and Future Plans
- 2.2 Johnson & Johnson
- 2.2.1 Johnson & Johnson Details
- 2.2.2 Johnson & Johnson Major Business
- 2.2.3 Johnson & Johnson Anti-inflammatory Therapeutics Product and Solutions
- 2.2.4 Johnson & Johnson Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
- 2.2.5 Johnson & Johnson Recent Developments and Future Plans
- 2.3 Amgen Inc
- 2.3.1 Amgen Inc Details
- 2.3.2 Amgen Inc Major Business
- 2.3.3 Amgen Inc Anti-inflammatory Therapeutics Product and Solutions
- 2.3.4 Amgen Inc Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
- 2.3.5 Amgen Inc Recent Developments and Future Plans
- 2.4 AstraZeneca PLC
- 2.4.1 AstraZeneca PLC Details
- 2.4.2 AstraZeneca PLC Major Business
- 2.4.3 AstraZeneca PLC Anti-inflammatory Therapeutics Product and Solutions
- 2.4.4 AstraZeneca PLC Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
- 2.4.5 AstraZeneca PLC Recent Developments and Future Plans
- 2.5 Pfizer, Inc
- 2.5.1 Pfizer, Inc Details
- 2.5.2 Pfizer, Inc Major Business
- 2.5.3 Pfizer, Inc Anti-inflammatory Therapeutics Product and Solutions
- 2.5.4 Pfizer, Inc Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
- 2.5.5 Pfizer, Inc Recent Developments and Future Plans
- 2.6 Novartis
- 2.6.1 Novartis Details
- 2.6.2 Novartis Major Business
- 2.6.3 Novartis Anti-inflammatory Therapeutics Product and Solutions
- 2.6.4 Novartis Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
- 2.6.5 Novartis Recent Developments and Future Plans
- 2.7 Roche
- 2.7.1 Roche Details
- 2.7.2 Roche Major Business
- 2.7.3 Roche Anti-inflammatory Therapeutics Product and Solutions
- 2.7.4 Roche Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
- 2.7.5 Roche Recent Developments and Future Plans
- 2.8 Merck
- 2.8.1 Merck Details
- 2.8.2 Merck Major Business
- 2.8.3 Merck Anti-inflammatory Therapeutics Product and Solutions
- 2.8.4 Merck Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
- 2.8.5 Merck Recent Developments and Future Plans
- 2.9 Sanofi
- 2.9.1 Sanofi Details
- 2.9.2 Sanofi Major Business
- 2.9.3 Sanofi Anti-inflammatory Therapeutics Product and Solutions
- 2.9.4 Sanofi Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
- 2.9.5 Sanofi Recent Developments and Future Plans
- 2.10 GlaxoSmithKline
- 2.10.1 GlaxoSmithKline Details
- 2.10.2 GlaxoSmithKline Major Business
- 2.10.3 GlaxoSmithKline Anti-inflammatory Therapeutics Product and Solutions
- 2.10.4 GlaxoSmithKline Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
- 2.10.5 GlaxoSmithKline Recent Developments and Future Plans
- 2.11 Sun Pharmaceutical Industries Ltd
- 2.11.1 Sun Pharmaceutical Industries Ltd Details
- 2.11.2 Sun Pharmaceutical Industries Ltd Major Business
- 2.11.3 Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Product and Solutions
- 2.11.4 Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
- 2.11.5 Sun Pharmaceutical Industries Ltd Recent Developments and Future Plans
- 2.12 TEVA
- 2.12.1 TEVA Details
- 2.12.2 TEVA Major Business
- 2.12.3 TEVA Anti-inflammatory Therapeutics Product and Solutions
- 2.12.4 TEVA Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
- 2.12.5 TEVA Recent Developments and Future Plans
3 Market Competition, by Players
- 3.1 Global Anti-inflammatory Therapeutics Revenue and Share by Players (2019-2024)
- 3.2 Market Share Analysis (2023)
- 3.2.1 Market Share of Anti-inflammatory Therapeutics by Company Revenue
- 3.2.2 Top 3 Anti-inflammatory Therapeutics Players Market Share in 2023
- 3.2.3 Top 6 Anti-inflammatory Therapeutics Players Market Share in 2023
- 3.3 Anti-inflammatory Therapeutics Market: Overall Company Footprint Analysis
- 3.3.1 Anti-inflammatory Therapeutics Market: Region Footprint
- 3.3.2 Anti-inflammatory Therapeutics Market: Company Product Type Footprint
- 3.3.3 Anti-inflammatory Therapeutics Market: Company Product Application Footprint
- 3.4 New Market Entrants and Barriers to Market Entry
- 3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
- 4.1 Global Anti-inflammatory Therapeutics Consumption Value and Market Share by Type (2019-2024)
- 4.2 Global Anti-inflammatory Therapeutics Market Forecast by Type (2025-2030)
5 Market Size Segment by Application
- 5.1 Global Anti-inflammatory Therapeutics Consumption Value Market Share by Application (2019-2024)
- 5.2 Global Anti-inflammatory Therapeutics Market Forecast by Application (2025-2030)
6 North America
- 6.1 North America Anti-inflammatory Therapeutics Consumption Value by Type (2019-2030)
- 6.2 North America Anti-inflammatory Therapeutics Market Size by Application (2019-2030)
- 6.3 North America Anti-inflammatory Therapeutics Market Size by Country
- 6.3.1 North America Anti-inflammatory Therapeutics Consumption Value by Country (2019-2030)
- 6.3.2 United States Anti-inflammatory Therapeutics Market Size and Forecast (2019-2030)
- 6.3.3 Canada Anti-inflammatory Therapeutics Market Size and Forecast (2019-2030)
- 6.3.4 Mexico Anti-inflammatory Therapeutics Market Size and Forecast (2019-2030)
7 Europe
- 7.1 Europe Anti-inflammatory Therapeutics Consumption Value by Type (2019-2030)
- 7.2 Europe Anti-inflammatory Therapeutics Consumption Value by Application (2019-2030)
- 7.3 Europe Anti-inflammatory Therapeutics Market Size by Country
- 7.3.1 Europe Anti-inflammatory Therapeutics Consumption Value by Country (2019-2030)
- 7.3.2 Germany Anti-inflammatory Therapeutics Market Size and Forecast (2019-2030)
- 7.3.3 France Anti-inflammatory Therapeutics Market Size and Forecast (2019-2030)
- 7.3.4 United Kingdom Anti-inflammatory Therapeutics Market Size and Forecast (2019-2030)
- 7.3.5 Russia Anti-inflammatory Therapeutics Market Size and Forecast (2019-2030)
- 7.3.6 Italy Anti-inflammatory Therapeutics Market Size and Forecast (2019-2030)
8 Asia-Pacific
- 8.1 Asia-Pacific Anti-inflammatory Therapeutics Consumption Value by Type (2019-2030)
- 8.2 Asia-Pacific Anti-inflammatory Therapeutics Consumption Value by Application (2019-2030)
- 8.3 Asia-Pacific Anti-inflammatory Therapeutics Market Size by Region
- 8.3.1 Asia-Pacific Anti-inflammatory Therapeutics Consumption Value by Region (2019-2030)
- 8.3.2 China Anti-inflammatory Therapeutics Market Size and Forecast (2019-2030)
- 8.3.3 Japan Anti-inflammatory Therapeutics Market Size and Forecast (2019-2030)
- 8.3.4 South Korea Anti-inflammatory Therapeutics Market Size and Forecast (2019-2030)
- 8.3.5 India Anti-inflammatory Therapeutics Market Size and Forecast (2019-2030)
- 8.3.6 Southeast Asia Anti-inflammatory Therapeutics Market Size and Forecast (2019-2030)
- 8.3.7 Australia Anti-inflammatory Therapeutics Market Size and Forecast (2019-2030)
9 South America
- 9.1 South America Anti-inflammatory Therapeutics Consumption Value by Type (2019-2030)
- 9.2 South America Anti-inflammatory Therapeutics Consumption Value by Application (2019-2030)
- 9.3 South America Anti-inflammatory Therapeutics Market Size by Country
- 9.3.1 South America Anti-inflammatory Therapeutics Consumption Value by Country (2019-2030)
- 9.3.2 Brazil Anti-inflammatory Therapeutics Market Size and Forecast (2019-2030)
- 9.3.3 Argentina Anti-inflammatory Therapeutics Market Size and Forecast (2019-2030)
10 Middle East & Africa
- 10.1 Middle East & Africa Anti-inflammatory Therapeutics Consumption Value by Type (2019-2030)
- 10.2 Middle East & Africa Anti-inflammatory Therapeutics Consumption Value by Application (2019-2030)
- 10.3 Middle East & Africa Anti-inflammatory Therapeutics Market Size by Country
- 10.3.1 Middle East & Africa Anti-inflammatory Therapeutics Consumption Value by Country (2019-2030)
- 10.3.2 Turkey Anti-inflammatory Therapeutics Market Size and Forecast (2019-2030)
- 10.3.3 Saudi Arabia Anti-inflammatory Therapeutics Market Size and Forecast (2019-2030)
- 10.3.4 UAE Anti-inflammatory Therapeutics Market Size and Forecast (2019-2030)
11 Market Dynamics
- 11.1 Anti-inflammatory Therapeutics Market Drivers
- 11.2 Anti-inflammatory Therapeutics Market Restraints
- 11.3 Anti-inflammatory Therapeutics Trends Analysis
- 11.4 Porters Five Forces Analysis
- 11.4.1 Threat of New Entrants
- 11.4.2 Bargaining Power of Suppliers
- 11.4.3 Bargaining Power of Buyers
- 11.4.4 Threat of Substitutes
- 11.4.5 Competitive Rivalry
12 Industry Chain Analysis
- 12.1 Anti-inflammatory Therapeutics Industry Chain
- 12.2 Anti-inflammatory Therapeutics Upstream Analysis
- 12.3 Anti-inflammatory Therapeutics Midstream Analysis
- 12.4 Anti-inflammatory Therapeutics Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
- 14.1 Methodology
- 14.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Anti-inflammatory Therapeutics. Industry analysis & Market Report on Anti-inflammatory Therapeutics is a syndicated market report, published as Global Anti-inflammatory Therapeutics Market 2024 by Company, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of Anti-inflammatory Therapeutics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
